Form 4 for SMMT Summit Therapeutics Inc.
Accepted 2025-10-23 00:00:00 ET · period of report 2025-10-21 · accession 0001890784-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-23 | 2025-10-21 | SMMT | Anand Bhaskar | CAO | A - Grant | $18.74 | +26.7K | 159.8K | +20% | +$500.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-21 | A | A | 26,680 | $18.74 | 159,751 | D | — | — | (F1) Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025. (F2) Holdings include shares previously acquired through exempt transactions pursuant to the Issuer's employee stock purchase plan. |